00775nas a2200277   4500000000100000000000100001008004100002653001600043653001300059653002400072653001700096653002900113653002400142653002000166100001500186700001500201700001200216700001300228700001300241700001700254700001200271700001300283245017200296250001500468020001400483       2023                            d10aDulaglutide10aGlp-1 ra10aObservational study10aprimary care10aSubcutaneous semaglutide10aTherapeutic inertia10aType 2 diabetes1 aL. von Arx1 aJ. Rachman1 aJ. Webb1 aC. Casey1 aA. Patel1 aC. Diomatari1 aR. Wood1 aI. Idris00aTherapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care  a2023/01/25  a1462-8902